Professor John B Kostis

Professor John B Kostis

Rutgers Robert Wood Johnson Medical School, New Brunswick (United States of America)

Member of:

Dr. Kostis, a graduate of the Medical School of the Aristoteleion University of Thessaloniki, Greece with a doctoral degree (DPhil) from the University of Athens has served as Chief of Cardiology, Chairman of the Department of Medicine for over 22 years and on the Board of Directors at the Robert Wood Johnson academic medical center in New Brunswick, New Jersey, USA. He occupies the first endowed Chair at that institution. Dr. Kostis developed state of the art tertiary cardiology in New Brunswick, NJ, established clinical research in cardiology, participated in the study and development of over 140 pharmacologic agents and devices and held leadership positions in large clinical trials sponsored by the NIH and the industry. He has published 7 books, one translated into German, over 500 publications. He has served as Associate Editor of Cardiology, Journal of the American Society of Hypertension, Current Hypertension Reviews, and the International Journal of Cardiology-Hypertension.

Presentations

Socioeconomic data predict adverse cardiovascular outcomes

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology

Session: Ventricular arrhythmias and sudden cardiac death e-posters

Access

High rate of stroke and low rate of atrial fibrillation in low socioeconomic strata and blacks: the atrial fibrillation paradox

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Arrhythmias, General ePosters

Access

U-curves in the intensive and standard groups of the systolic blood pressure intervention trial

Event: ESC Congress 2018

Topic: Clinical

Session: Sex, drugs and blood pressure control

Access

Frequency and outcomes of patients who leave the hospital against medical advice

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Acute coronary syndrome outcome

Access

Effect of the magnitude of LDL lowering on the incidence of cataract among patients treated with statins or PCSK9 antibodies

Event: ESC Congress 2017

Topic: Lipids (Epidemiology and Prevention)

Session: Cholesterol-lowering therapy for primary and secondary prevention

Access

Predictors of multiple percutaneous coronary interventions in a statewide database of 114,588 patients

Event: ESC Congress 2017

Topic: PCI: long-term outcome

Session: Long-Term outcomes of PCI

Access

Professor John B Kostis

Biography

Contributor content

Socioeconomic data predict adverse cardiovascular outcomes

High rate of stroke and low rate of atrial fibrillation in low socioeconomic strata and blacks: the atrial fibrillation paradox

U-curves in the intensive and standard groups of the systolic blood pressure intervention trial

Frequency and outcomes of patients who leave the hospital against medical advice

Effect of the magnitude of LDL lowering on the incidence of cataract among patients treated with statins or PCSK9 antibodies

Predictors of multiple percutaneous coronary interventions in a statewide database of 114,588 patients

ESC 365 is supported by